비교리스트

 카트 문의
시장보고서
상품코드
1347168

내피기능장애 시장 예측(-2028년) - 원인, 검사 유형, 최종사용자별 세계 분석

Endothelial Dysfunction Market Forecast to 2028 - Global Analysis by Cause, Test Type, and End User
발행일: | 리서치사: The Insight Partners | 페이지 정보: 영문 198 Pages | 배송안내 : 즉시배송

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 내피기능장애 시장 규모는 2022년 19억 9,517만 달러로 평가되며 2028년에는 25억 8,484만 달러에 달할 것으로 예상되며, 시장은 2022년부터 2028년까지 4.4%의 CAGR을 기록할 것으로 추정됩니다. 시장 성장은 심혈관 질환 발병률 증가, 고콜레스테롤, 당뇨병, 비만 발병률 증가에 기인합니다.

세계보건기구(WHO)에 따르면, 심혈관질환(CVD)은 전 세계 주요 사망 원인 중 하나로 매년 3,000만 명이 뇌졸중을 경험하고 있으며, CVD에는 뇌혈관질환, 관상동맥질환, 류마티스성 심장질환, 관상동맥질환(CAD)이 포함되며, CAD는 심혈관질환 중 가장 흔한 질환입니다. 중 가장 흔한 질환으로, 관상동맥 내피하 공간에 지질과 면역세포가 축적되는 동맥경화를 특징으로 합니다. 혈관 내피의 염증 반응이 관여하는 CAD는 죽상동맥경화로 인한 관상동맥 내강의 협착, 경련, 막힘으로 인한 심근의 허혈, 저산소증, 괴사를 특징으로 합니다. 전 세계적으로 사망 원인 1위로 꼽힙니다. 미국 질병예방통제센터(CDC)에 따르면 미국에서는 6,000만 명 이상의 여성(44%)이 심장 질환을 앓고 있습니다. 심장병은 미국 여성 사망 원인 1위이며, 연령에 관계없이 발병할 수 있으며, 2021년에는 여성 사망자 5명 중 1명인 310,661명이 심장병으로 사망할 것으로 예상됩니다. 뉴델리 국립심장연구소의 C.E.O. 겸 수석 심장외과 전문의인 O. Yadava 박사의 '젊은 인도인은 관상동맥질환의 위험이 높다'라는 제목의 논문에 따르면, 현재의 과학적 증거는 놀라운 결과를 보여줍니다. 유럽과 미국에서 CAD의 유병률은 지난 30년간 절반으로 감소했습니다. 그러나 인도에서는 두 배로 증가했으며 감소할 기미가 보이지 않습니다.

미국심장협회에 따르면 미국 성인의 거의 절반이 CVD를 앓고 있으며, 2035년까지 미국 인구의 45.1%인 1억 3,000만 명 이상이 CVD를 앓을 것으로 예측됩니다. 유럽심장학회에 따르면, CVD는 유럽에서 390만 명, 유럽연합(EU)에서 180만 명 이상이 사망하는 원인이 되고 있습니다. 즉, 유럽 전체 사망의 45%를 차지합니다. 지난 25년 동안 유럽에서 CVD의 절대적인 수와 새로운 CVD 사례의 수가 증가했습니다. 중유럽과 서유럽에서는 남성의 흡연 습관과 과음으로 인해 심혈관 위험요인의 유병률이 높습니다. 매년 400만 명 이상의 유럽인이 관상동맥질환(CHD)과 뇌졸중으로 인한 심혈관질환으로 사망하고 있습니다. 2019년 발간된 바이오센스 웹스터(Biosense Webster)의 보고서 "Beyond the Burden: 아시아태평양의 심방세동 영향"에 따르면 아시아태평양에서는 1,600만 명 이상이 심방세동을 앓고 있으며, 2050년에는 7,200만 명에 달할 것으로 예상합니다. 에 도달할 것으로 예상됩니다. 이 보고서는 또한 중장년층이 이 질환에 걸리기 쉽다는 것을 시사하고 있습니다.

세계심장연맹에 따르면 심혈관 질환은 중동 및 북아프리카의 주요 사망 원인으로 전체 사망자의 3분의 1 이상, 연간 140만 명이 사망하는 것으로 나타났습니다. 또한 CVD로 인한 사망은 지난 30년간 48% 증가했으며, 오만과 소말리아에서 각각 40%와 10%를 차지하며, 2021년 중동 및 북아프리카의 연령표준화 CVD 사망률은 인구 10만 명당 134.2-600.2명이었습니다.

따라서 심혈관 질환의 높은 유병률은 내피기능장애 시장의 성장을 촉진할 것으로 보입니다.

제품 기반 인사이트

내피기능장애 시장은 원인별로 고혈압, 당뇨병, 고콜레스테롤혈증, 베체트병, 비만, 기타로 구분되며, 2022년 고혈압 부문이 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 그러나 당뇨병 부문은 2022-2028년 동안 시장에서 가장 높은 CAGR 4.6%를 기록할 것으로 예상됩니다. 심혈관 합병증은 당뇨병으로 인한 만성 혈관 합병증의 결과입니다. 많은 연구 논문에서 인슐린 저항성과 내피기능장애의 연관성을 보여주었습니다. 그러나 당뇨병이 내피에 어떤 영향을 미치는지는 아직 밝혀지지 않았습니다. 당뇨병은 동맥경화성 질환, 망막증, 신증, 신경장애 등 미세혈관 병변의 위험과 직접적인 관련이 있습니다. 2020년 5월 MDPI 저널에 발표된 연구 논문 '당뇨병의 내피기능장애'에 따르면, 공복혈당장애(IFG), 내당능장애(IGT)와 같은 당뇨병 전단계 환자에서도 내피기능장애를 이벤트로서 내피기능장애를 시사하는 근거가 축적되고 있습니다. 위의 요인을 고려하면 내피기능장애 치료 수요는 기하급수적으로 증가할 것으로 추정됩니다.

원인에 기반한 인사이트

원인에 따라 내피기능장애 시장은 고혈압, 당뇨병, 고콜레스테롤혈증, 베체트병, 비만, 기타로 분류되며, 2022년 내피기능장애 시장 점유율은 고혈압이 가장 큰 비중을 차지할 것으로 예상됩니다. 당뇨병 부문은 2022년부터 2028년까지 가장 높은 CAGR을 기록할 것으로 예상됩니다.

최종사용자에 기반한 인사이트

최종사용자에 따라 내피기능장애 시장은 병원, 진단 센터, 클리닉 및 기타로 분류됩니다. 병원은 2022년 가장 큰 시장 점유율을 차지하고 2022년부터 2028년까지 가장 높은 CAGR을 기록할 것으로 예상됩니다.

또한 당뇨병 환자 수는 전 세계적으로 광범위하게 증가하고 있습니다. 국제 당뇨병 연합(IDF)에 따르면 2045 년까지 당뇨병 환자 수는 2020년 4억 2,500 만 명에서 6억 명으로 증가할 것으로 예상됩니다. 따라서 당뇨병 환자의 증가는 당뇨병 부문의 내피기능장애 시장의 성장을 촉진할 것입니다.

목차

제1장 서론

제2장 내피기능장애 시장 - 주요 요점

제3장 조사 방법

  • 조사 범위
  • 2차 조사
  • 1차 조사

제4장 내피기능장애 시장 - 시장 상황

  • 개요
  • PEST 분석
    • 북미 PEST 분석
    • 유럽 PEST 분석
    • 아시아태평양 PEST 분석
    • 중동 및 아프리카 PEST 분석
    • 중남미 PEST 분석
  • 전문가의 견해

제5장 내피기능장애 시장 : 주요 시장 역학

  • 시장 성장 촉진요인
    • 심혈관질환 증가
    • 고콜레스테롤, 당뇨병, 비만 증가
  • 시장 성장 억제요인
    • 내피기능장애 스크리닝 기술에 따른 결점
  • 시장 기회
    • 신규 바이오마커와 치료 전략 이용 증가
  • 향후 동향
    • 내피기능장애를 평가하기 위한 비침습적 방법 사용
  • 영향 분석

제6장 내피기능장애 시장 - 세계 분석

  • 내피기능장애 세계 시장 매출과 예측 분석
  • 내피기능장애 세계 시장 : 지역별 예측·분석
  • 주요 진출 기업 시장 포지셔닝

제7장 내피기능장애 시장 분석 - 원인별

  • 개요
  • 내피기능장애 시장 : 원인별, 2022년·2028년(%)
  • 고혈압
  • 당뇨병
  • 고콜레스테롤혈증
  • 베체트병
  • 비만
  • 기타

제8장 내피기능장애 시장 분석 - 검사 유형별

  • 개요
  • 내피기능장애 시장 : 검사 유형별, 2022년·2028년(%)
  • 침습적 검사
  • 비침습적 검사

제9장 내피기능장애 시장 분석 - 최종사용자별

  • 개요
  • 내피기능장애 시장 : 최종사용자별, 2022년·2028년(%)
  • 병원
  • 진단 센터
  • 진료소
  • 기타

제10장 내피기능장애 시장 : 2028년까지 매출과 예측 : 지역 분석

  • 북미
  • 유럽
  • 아시아태평양
  • 중동 및 아프리카
  • 중남미

제11장 내피기능장애 시장에 대한 COVID-19 팬데믹의 영향

  • 북미
  • 유럽
  • 아시아태평양
  • 중남미
  • 중동 및 아프리카

제12장 내피기능장애 시장 - 업계 상황

  • 내피기능장애 시장의 성장 전략
  • 무기적 성장 전략
  • 유기적 성장 전략

제13장 기업 개요

  • ZOLL Medical Corp
  • Sphingo Tec GmbH
  • Lawrence Berkeley National Laboratory
  • The Polymath Co
  • Endothelix Inc
  • Perimed AB
  • SMART Medical Ltd
  • Everist Health Inc
  • Alam Medical SaRl
  • Medizinische Messtechnik GmbH

제14장 부록

ksm 23.10.25

The global endothelial dysfunction market size was valued at US$ 1,995.17 million in 2022 and is expected to reach a value of US$ 2,584.84 million by 2028; the market is estimated to record a CAGR of 4.4% from 2022 to 2028. The market growth is attributed to increasing incidence of cardiovascular diseases and rising incidence of high cholesterol, diabetes, and obesity.

According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are among the leading causes of death worldwide, and ~30 million people experience a stroke each year. CVDs include cerebrovascular disease, coronary heart disease, rheumatic heart disease, and coronary artery disease (CAD). CAD is the most common disease among all cardiovascular diseases, and it is characterized by the accumulation of lipids and immune cells in the subendothelial space of the coronary arteries or atherosclerosis. It involves the inflammatory response of the vascular endothelium. CAD is characterized by ischemia, hypoxia, or necrosis of the myocardium resulting from narrowing, spasm, or obstruction of the coronary artery lumen by atherosclerosis. It has become the leading cause of death worldwide. According to the Centers for Disease Control and Prevention (CDC), over 60 million women (44%) in the US suffer from some form of heart disease. Heart disease is the leading cause of death among women in the US and can affect women of any age. In 2021, it caused 310,661 deaths among women, i.e., nearly one in five female deaths. According to an article entitled "Young Indians Are at Higher Risk of Coronary Artery Disease," by Dr. O. Yadava, C.E.O. & Chief Cardiac Surgeon, National Heart Institute, New Delhi, current scientific evidence shows alarming results; CAD rates among Indians are staggering 50-400% higher than any other ethnic group. The prevalence of CAD in the West has fallen by half over the past three decades. However, the rates in India have doubled, and there is no sign of a decline.

According to the American Heart Association, almost half of all adults in the US suffer from a type of CVD. Over 130 million people, i.e., 45.1% of the US population, are projected to suffer from a type of CVD by 2035. According to reports by the European Society of Cardiology, CVDs cause 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (EU). In short, they account for 45% of all deaths in Europe. Over the past 25 years, the absolute number of CVD cases and new CVD cases have increased in Europe. There is a high prevalence of cardiovascular risk factors in Central and Western Europe owing to smoking habits and heavy drinking rates among men. More than 4 million Europeans die yearly from cardiovascular diseases mainly due to coronary artery disease (CHD) and stroke. As per the report "Beyond the Burden: The Impact of Atrial Fibrillation in Asia Pacific," by Biosense Webster, published in 2019, more than 16 million people in Asia Pacific suffer from atrial fibrillation, which is expected to reach ~72 million by 2050. The report also suggests that the middle-aged and elderly population is more prone to develop this condition.

According to the World Heart Federation, cardiovascular disease is the primary cause of death in the Middle East & North Africa, accounting for more than a third of all deaths or 1.4 million people annually. Further, CVD deaths have increased by 48% over the past 30 years, which accounted for 40% and 10% of deaths in Oman and Somalia, respectively. In 2021, age-standardized CVD mortality rates in the Middle East & North Africa ranged from 134.2 to 600.2 per 100,000 people.

Therefore, the high prevalence of cardiovascular diseases is likely to drive the endothelial dysfunction market growth.

Product-Based Insights

The endothelial dysfunction market, based on cause, is segmented into hypertension, diabetes, hypercholestrolaemia, Bechet's disease, obesity, and others. The hypertension segment held the largest share of the market in 2022. However, diabetes segment is anticipated to register the highest CAGR of 4.6% in the market during 2022-2028. Cardiovascular complications are the results of chronic vascular complications caused by diabetes. Many research articles have shown links between insulin resistance and endothelial dysfunction. However, it is still not understood how diabetes affects endothelium. Diabetes is directly related to risks of microvascular pathologies, such as atherosclerotic diseases, retinopathy, nephropathy, and neuropathy. Thus, the risk of cardiovascular disease increases exponentially in patients suffering from diabetes. According to the research article 'Endothelial Dysfunction in Diabetes,' published in May 2020 by MDPI journals, patients with prediabetic conditions, such as impaired fasting glucose (IFG) and impaired glucose tolerance (IGT), also show accumulating evidence that implicates endothelial dysfunction as an event. Considering the above-listed factors, the demand for endothelial dysfunction treatment is estimated to increase exponentially.

Cause-Based Insights

Based on cause, the endothelial dysfunction market is segmented into hypertension, diabetes, hypercholestrolaemia, Bechet's disease, obesity, and others. Hypertension was the largest endothelial dysfunction market share holder in 2022. The diabetes segment is anticipated to register the highest CAGR from 2022 to 2028.

End User-Based Insights

Based on end user, the endothelial dysfunction market is categorized into hospitals, diagnostic centers, clinics, and others. Hospitals was the largest market share holder in 2022 and is anticipated to register the highest CAGR from 2022 to 2028.

Further, the number of people with diabetes is growing widely worldwide. According to the International Diabetes Federation (IDF), by 2045, the number of people with diabetes will rise to 600 million from 425 million in 2020. Thus, the growing number of diabetic people drives the endothelial dysfunction market growth for the diabetes segment.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the endothelial dysfunction market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global endothelial dysfunction market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the endothelial dysfunction market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Endothelial Dysfunction Market - by Cause
    • 1.3.2 Global Endothelial Dysfunction Market - by Test Type
    • 1.3.3 Global Endothelial Dysfunction Market - by End User
    • 1.3.4 Global Endothelial Dysfunction Market - by Geography

2. Endothelial Dysfunction Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Endothelial Dysfunction Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East and Africa PEST Analysis
    • 4.2.5 South and Central America PEST Analysis
  • 4.3 Expert Opinion

5. Endothelial Dysfunction Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Incidences of Cardiovascular Diseases
    • 5.1.2 Rising Incidences of High Cholesterol, Diabetes And Obesity
  • 5.2 Market Restraints
    • 5.2.1 Disadvantages Associated with the Techniques for Screening of Endothelial Dysfunction
  • 5.3 Market Opportunities
    • 5.3.1 Rising Usage of Novel Biomarkers and Therapeutic Strategies
  • 5.4 Future Trends
    • 5.4.1 Use of Noninvasive Methods to Assess Endothelial Dysfunction
  • 5.5 Impact Analysis

6. Endothelial Dysfunction Market - Global Analysis

  • 6.1 Global Endothelial Dysfunction Market Revenue Forecast and Analysis
  • 6.2 Global Endothelial Dysfunction Market, by Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Endothelial Dysfunction Market Analysis - by Cause

  • 7.1 Overview
  • 7.2 Endothelial Dysfunction Market, By Cause, 2022 & 2028 (%)
  • 7.3 Hypertension
    • 7.3.1 Overview
    • 7.3.2 Hypertension: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Diabetes
    • 7.4.1 Overview
    • 7.4.2 Diabetes: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Hypercholestrolaemia
    • 7.5.1 Overview
    • 7.5.2 Hypercholestrolaemia: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Behcet's Disease
    • 7.6.1 Overview
    • 7.6.2 Behcet's Disease: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.7 Obesity
    • 7.7.1 Overview
    • 7.7.2 Obesity: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

8. Endothelial Dysfunction Market Analysis - by Test Type

  • 8.1 Overview
  • 8.2 Endothelial Dysfunction Market, By Test Type, 2022 & 2028 (%)
  • 8.3 Invasive Tests
    • 8.3.1 Overview
    • 8.3.2 Invasive Tests: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Non-Invasive Tests
    • 8.4.1 Overview
    • 8.4.2 Non-Invasive Tests: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.3 Flow Mediated Dilatory
      • 8.4.3.1 Overview
      • 8.4.3.2 Flow Mediated Dilatory: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.4 Venous Occlusion Plethysmography
      • 8.4.4.1 Overview
      • 8.4.4.2 Venous Occlusion Plethysmography: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.5 Peripheral Arterial Tonometry (PAT)
      • 8.4.5.1 Overview
      • 8.4.5.2 Peripheral Arterial Tonometry (PAT): Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.6 Circulating Markers
      • 8.4.6.1 Overview
      • 8.4.6.2 Circulating Markers: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.7 Others
      • 8.4.7.1 Overview
      • 8.4.7.2 Others: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

9. Endothelial Dysfunction Market Analysis - by End User

  • 9.1 Overview
  • 9.2 Endothelial Dysfunction Market, By End User, 2022 & 2028 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Diagnostics Centers
    • 9.4.1 Overview
    • 9.4.2 Diagnostics Centers: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Clinics
    • 9.5.1 Overview
    • 9.5.2 Clinics: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

10. Endothelial Dysfunction Market - Revenue and Forecast to 2028 - Geographic Analysis

  • 10.1 North America: Endothelial Dysfunction Market
    • 10.1.1 Overview
    • 10.1.2 North America: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.1.3 North America: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    • 10.1.4 North America: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
      • 10.1.4.1 North America: Endothelial Dysfunction Market, by Non-Invasive Tests- 2020-2028 (US$ Million)
    • 10.1.5 North America: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.5.1 US: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.1.1 Overview
        • 10.1.5.1.2 US: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.1.3 US: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.5.1.4 US: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.5.1.4.1 US: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.5.1.5 US: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.5.2 Canada: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.2.1 Overview
        • 10.1.5.2.2 Canada: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.2.3 Canada: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.5.2.4 Canada: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.5.2.4.1 Canada: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.5.2.5 Canada: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.5.3 Mexico: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.3.1 Overview
        • 10.1.5.3.2 Mexico: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.3.3 Mexico: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.5.3.4 Mexico: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.5.3.4.1 Mexico: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.5.3.5 Mexico: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  • 10.2 Europe: Endothelial Dysfunction Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.2.3 Europe: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    • 10.2.4 Europe: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
      • 10.2.4.1 Europe: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.5 Europe: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.2.5.1 Germany: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.5.1.1 Overview
        • 10.2.5.1.2 Germany: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.5.1.3 Germany: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.2.5.1.4 Germany: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.2.5.1.4.1 Germany: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.1.5 Germany: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.2.5.2 UK: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.5.2.1 Overview
        • 10.2.5.2.2 UK: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.5.2.3 UK: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.2.5.2.4 UK: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.2.5.2.4.1 UK: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.2.5 UK: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.2.5.3 France: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.5.3.1 Overview
        • 10.2.5.3.2 France: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.5.3.3 France: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.2.5.3.4 France: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.2.5.3.4.1 France: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.3.5 France: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.2.5.4 Italy: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.5.4.1 Overview
        • 10.2.5.4.2 Italy: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.5.4.3 Italy: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.2.5.4.4 Italy: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.2.5.4.4.1 Italy: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.4.5 Italy: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.2.5.5 Spain: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.5.5.1 Overview
        • 10.2.5.5.2 Spain: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.5.5.3 Spain: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.2.5.5.4 Spain: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.2.5.5.4.1 Spain: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.5.5 Spain: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.2.5.6 Rest of Europe: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.5.6.1 Overview
        • 10.2.5.6.2 Rest of Europe: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.5.6.3 Rest of Europe: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.2.5.6.4 Rest of Europe: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.2.5.6.4.1 Rest of Europe: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.6.5 Rest of Europe: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  • 10.3 Asia Pacific: Endothelial Dysfunction Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.3.3 Asia Pacific: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    • 10.3.4 Asia Pacific: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
      • 10.3.4.1 Asia Pacific: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    • 10.3.5 Asia Pacific: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.3.5.1 China: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.1.1 Overview
        • 10.3.5.1.2 China: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.1.3 China: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.3.5.1.4 China: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.3.5.1.4.1 China: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.3.5.1.5 China: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.3.5.2 Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.2.1 Overview
        • 10.3.5.2.2 Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.2.3 Japan: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.3.5.2.4 Japan: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.3.5.2.4.1 Japan: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.3.5.2.5 Japan: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.3.5.3 India: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.3.1 Overview
        • 10.3.5.3.2 India: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.3.3 India: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.3.5.3.4 India: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.3.5.3.4.1 India: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.3.5.3.5 India: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.3.5.4 Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.4.1 Overview
        • 10.3.5.4.2 Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.4.3 Australia: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.3.5.4.4 Australia: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.3.5.4.4.1 Australia: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.3.5.4.5 Australia: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.3.5.5 South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.5.1 Overview
        • 10.3.5.5.2 South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.5.3 South Korea: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.3.5.5.4 South Korea: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.3.5.5.4.1 South Korea: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.3.5.5.5 South Korea: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.3.5.6 Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.6.1 Overview
        • 10.3.5.6.2 Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.6.3 Rest of Asia Pacific: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.3.5.6.4 Rest of Asia Pacific: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.3.5.6.4.1 Rest of Asia Pacific: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.3.5.6.5 Rest of Asia Pacific: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  • 10.4 Middle East & Africa: Endothelial Dysfunction Market
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.4.3 Middle East & Africa: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    • 10.4.4 Middle East & Africa: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
      • 10.4.4.1 Middle East & Africa: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    • 10.4.5 Middle East & Africa: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.4.5.1 Saudi Arabia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.1.1 Overview
        • 10.4.5.1.2 Saudi Arabia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.1.3 Saudi Arabia: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.4.5.1.4 Saudi Arabia: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.4.5.1.4.1 Saudi Arabia: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.4.5.1.5 Saudi Arabia: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.4.5.2 UAE: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.2.1 Overview
        • 10.4.5.2.2 UAE: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.2.3 UAE: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.4.5.2.4 UAE: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.4.5.2.4.1 UAE: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.4.5.2.5 UAE: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.4.5.3 South Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.3.1 Overview
        • 10.4.5.3.2 South Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.3.3 South Africa: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.4.5.3.4 South Africa: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.4.5.3.4.1 South Africa: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.4.5.3.5 South Africa: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.4.5.4 Rest of Middle East & Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.4.1 Overview
        • 10.4.5.4.2 Rest of Middle East & Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.4.3 Rest of Middle East & Africa: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.4.5.4.4 Rest of Middle East & Africa: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.4.5.4.4.1 Rest of Middle East & Africa: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.4.5.4.5 Rest of Middle East & Africa: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  • 10.5 South & Central America: Endothelial Dysfunction Market
    • 10.5.1 Overview
    • 10.5.2 South & Central America: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.5.3 South & Central America: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    • 10.5.4 South & Central America: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
      • 10.5.4.1 South & Central America: Endothelial Dysfunction Market, by Non-Invasive Test - Revenue and Forecast to 2028 (US$ Million)
    • 10.5.5 South & Central America: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.5.5.1 Brazil: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.5.1.1 Overview
        • 10.5.5.1.2 Brazil: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.5.1.3 Brazil: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.5.5.1.4 Brazil: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.5.5.1.4.1 Brazil: Endothelial Dysfunction Market, by Non-Invasive Test - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.5.1.5 Brazil: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.5.5.2 Argentina: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.5.2.1 Overview
        • 10.5.5.2.2 Argentina: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.5.2.3 Argentina: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.5.5.2.4 Argentina: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.5.5.2.4.1 Argentina: Endothelial Dysfunction Market, by Non-Invasive Test - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.5.2.5 Argentina: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.5.5.3 Rest of South & Central America: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.5.3.1 Overview
        • 10.5.5.3.2 Rest of South & Central America: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.5.3.3 Rest of South & Central America: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.5.5.3.4 Rest of South & Central America: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.5.5.3.4.1 Rest of South & Central America: Endothelial Dysfunction Market, by Non-Invasive Test - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.5.3.5 Rest of South & Central America: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Endothelial Dysfunction Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 South & Central America: Impact Assessment of COVID-19 Pandemic
  • 11.5 Middle East & Africa: Impact Assessment of COVID-19 Pandemic

12. Endothelial Dysfunction Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Endothelial Dysfunction Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 ZOLL Medical Corp
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Sphingo Tec GmbH
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Lawrence Berkeley National Laboratory
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 The Polymath Co
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Endothelix Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Perimed AB
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 SMART Medical Ltd
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Everist Health Inc
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Alam Medical SaRl
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Medizinische Messtechnik GmbH
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제